Investigation into the effects of food allergen specific immunotherapy on ulcerative colitis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045199

Enrollment

Unknown

Registered

2021-04-08

Start date

2021-04-07

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic intestinal inflammation

Interventions

Treatment group:LTC/OVA liposome vaccine

placebo group:Saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulcerative colitis patients, allergic to eggs.

Exclusion criteria

Exclusion criteria: Autoimmune diseases, cancers.

Design outcomes

Primary

Measure	Time frame
Clinical symptoms of UC;	—

Countries

China

Contacts

Public ContactYang Pingchang

Shenzhen University

pcy2356@163.com+86 13823356269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026